RECRUITING

Home Blood Transfusions

Description

This is a pilot single arm study to evaluate the feasibility and acceptability of a home blood transfusion program. Patients will be enrolled with hematologic malignancies and other bone marrow failure syndromes who are transfusion dependent and interested in a home blood transfusion program. Participants enrolled in the study will receive 1-5 units of blood products at home. Data on barriers to administration will be recorded. Surveys and qualitative interviews will be completed to better understand acceptability of the program.

Conditions

Hematologic MalignancyMyelodysplastic SyndromesAcute Myeloid LeukemiaTransfusion Dependent Cytopenias
Talk to us

Related Conditions:

Hematologic MalignancyMyelodysplastic SyndromesAcute Myeloid LeukemiaTransfusion Dependent Cytopenias

Study Overview

On this page

Study Details

Study overview

This is a pilot single arm study to evaluate the feasibility and acceptability of a home blood transfusion program. Patients will be enrolled with hematologic malignancies and other bone marrow failure syndromes who are transfusion dependent and interested in a home blood transfusion program. Participants enrolled in the study will receive 1-5 units of blood products at home. Data on barriers to administration will be recorded. Surveys and qualitative interviews will be completed to better understand acceptability of the program.

A Pilot Study of Home Blood Transfusions for Patient With Cancer Who Have Transfusion Dependent Cytopenias

Home Blood Transfusions

Condition
Hematologic Malignancy
Intervention / Treatment

-

Contacts and Locations

Philadelphia

Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States, 19107

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Individuals must meet all of the following inclusion criteria in order to be eligible to participate in the study:
  • * Provide signed and dated informed consent form Willing to comply with all study procedures and be available for the duration of the study
  • * Male or female, over the age of 18
  • * Must meet definition of transfusion dependence (require at least 2 blood product transfusions over a 28-day period)
  • * Receive their cancer care at SKCCC
  • * Have a history of blood product transfusions and NO history of transfusion reactions,
  • * Live within a 30-mile range of the Center City SKCCC location.
  • * Must be willing to allow people into the home
  • * An individual who meets any of the following criteria will be excluded from participation in this study:
  • * Patients who have a history of a transfusion reaction
  • * Heart failure as defined by AHA stage C or NYHA Class II-IV
  • * Non-English or Spanish speaking
  • * Are unhoused
  • * Are incarcerated
  • * Have poor venous access
  • * Diagnosis of Solid Tumor malignancy
  • * Women who are pregnant

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Thomas Jefferson University,

Study Record Dates

2027-06